Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery

Paul A. Carless, D. A. Henry

Research output: Contribution to journalReview articleResearchpeer-review

95 Citations (Scopus)

Abstract

Background: The use of fibrin sealant has been proposed as a means of preventing seroma formation following breast cancer surgery. Conflicting trial results require the efficacy of fibrin sealant to be reviewed critically. Methods: A systematic review of randomized controlled trials was conducted to examine the efficacy of fibrin sealants in reducing postoperative drainage and seroma formation after breast cancer surgery. Studies were identified by computer searches of Medline, Embase, the Cochrane Central Register of Controlled Trials and manufacturer websites (to June 2005), and bibliographic searches of published articles. Trials were eligible for inclusion if they reported data on postoperative drainage and the number of patients who developed a seroma. Results: Eleven trials met the criteria for inclusion. Generally, the trials were small and of poor methodological quality. Fibrin sealant did not reduce the rate of postoperative seroma (relative risk 1.14, 95 percent confidence interval (c.i.) 0.88 to 1.46), the volume of drainage (weighted mean difference - 117.7, 95 percent c.i. - 259.2 to 23.8 ml), or the length of hospital stay (weighted mean difference - 0.38, 95 per cent c.i. - 1.58 to 0.83 days). Conclusions: The current evidence does not support the use of fibrin sealant in breast cancer surgery to reduce postoperative drainage or seroma formation.

Original languageEnglish
Pages (from-to)810-819
Number of pages10
JournalBritish Journal of Surgery
Volume93
Issue number7
DOIs
Publication statusPublished - Jul 2006
Externally publishedYes

Fingerprint

Seroma
Fibrin Tissue Adhesive
Meta-Analysis
Breast Neoplasms
Drainage
Confidence Intervals
Length of Stay
Randomized Controlled Trials

Cite this

@article{e329c77bcb194572b53e2d4b73452271,
title = "Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery",
abstract = "Background: The use of fibrin sealant has been proposed as a means of preventing seroma formation following breast cancer surgery. Conflicting trial results require the efficacy of fibrin sealant to be reviewed critically. Methods: A systematic review of randomized controlled trials was conducted to examine the efficacy of fibrin sealants in reducing postoperative drainage and seroma formation after breast cancer surgery. Studies were identified by computer searches of Medline, Embase, the Cochrane Central Register of Controlled Trials and manufacturer websites (to June 2005), and bibliographic searches of published articles. Trials were eligible for inclusion if they reported data on postoperative drainage and the number of patients who developed a seroma. Results: Eleven trials met the criteria for inclusion. Generally, the trials were small and of poor methodological quality. Fibrin sealant did not reduce the rate of postoperative seroma (relative risk 1.14, 95 percent confidence interval (c.i.) 0.88 to 1.46), the volume of drainage (weighted mean difference - 117.7, 95 percent c.i. - 259.2 to 23.8 ml), or the length of hospital stay (weighted mean difference - 0.38, 95 per cent c.i. - 1.58 to 0.83 days). Conclusions: The current evidence does not support the use of fibrin sealant in breast cancer surgery to reduce postoperative drainage or seroma formation.",
author = "Carless, {Paul A.} and Henry, {D. A.}",
year = "2006",
month = "7",
doi = "10.1002/bjs.5432",
language = "English",
volume = "93",
pages = "810--819",
journal = "European Journal of Surgery, Acta Chirurgica",
issn = "0007-1323",
publisher = "John Wiley & Sons",
number = "7",

}

Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery. / Carless, Paul A.; Henry, D. A.

In: British Journal of Surgery, Vol. 93, No. 7, 07.2006, p. 810-819.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery

AU - Carless, Paul A.

AU - Henry, D. A.

PY - 2006/7

Y1 - 2006/7

N2 - Background: The use of fibrin sealant has been proposed as a means of preventing seroma formation following breast cancer surgery. Conflicting trial results require the efficacy of fibrin sealant to be reviewed critically. Methods: A systematic review of randomized controlled trials was conducted to examine the efficacy of fibrin sealants in reducing postoperative drainage and seroma formation after breast cancer surgery. Studies were identified by computer searches of Medline, Embase, the Cochrane Central Register of Controlled Trials and manufacturer websites (to June 2005), and bibliographic searches of published articles. Trials were eligible for inclusion if they reported data on postoperative drainage and the number of patients who developed a seroma. Results: Eleven trials met the criteria for inclusion. Generally, the trials were small and of poor methodological quality. Fibrin sealant did not reduce the rate of postoperative seroma (relative risk 1.14, 95 percent confidence interval (c.i.) 0.88 to 1.46), the volume of drainage (weighted mean difference - 117.7, 95 percent c.i. - 259.2 to 23.8 ml), or the length of hospital stay (weighted mean difference - 0.38, 95 per cent c.i. - 1.58 to 0.83 days). Conclusions: The current evidence does not support the use of fibrin sealant in breast cancer surgery to reduce postoperative drainage or seroma formation.

AB - Background: The use of fibrin sealant has been proposed as a means of preventing seroma formation following breast cancer surgery. Conflicting trial results require the efficacy of fibrin sealant to be reviewed critically. Methods: A systematic review of randomized controlled trials was conducted to examine the efficacy of fibrin sealants in reducing postoperative drainage and seroma formation after breast cancer surgery. Studies were identified by computer searches of Medline, Embase, the Cochrane Central Register of Controlled Trials and manufacturer websites (to June 2005), and bibliographic searches of published articles. Trials were eligible for inclusion if they reported data on postoperative drainage and the number of patients who developed a seroma. Results: Eleven trials met the criteria for inclusion. Generally, the trials were small and of poor methodological quality. Fibrin sealant did not reduce the rate of postoperative seroma (relative risk 1.14, 95 percent confidence interval (c.i.) 0.88 to 1.46), the volume of drainage (weighted mean difference - 117.7, 95 percent c.i. - 259.2 to 23.8 ml), or the length of hospital stay (weighted mean difference - 0.38, 95 per cent c.i. - 1.58 to 0.83 days). Conclusions: The current evidence does not support the use of fibrin sealant in breast cancer surgery to reduce postoperative drainage or seroma formation.

UR - http://www.scopus.com/inward/record.url?scp=33745860385&partnerID=8YFLogxK

U2 - 10.1002/bjs.5432

DO - 10.1002/bjs.5432

M3 - Review article

VL - 93

SP - 810

EP - 819

JO - European Journal of Surgery, Acta Chirurgica

JF - European Journal of Surgery, Acta Chirurgica

SN - 0007-1323

IS - 7

ER -